Article
Similarities between Methamphetamine Toxicity and Proteasome Inhibition
1 Oct 2004
Abstract excerpt
The monoamine neurotoxin methamphetamine (METH) is commonly used as an experimental model for Parkinson's disease (PD). In fact, METH-induced striatal dopamine (DA) loss is accompanied by damage to striatal nerve endings arising from the substantia nigra. On the other hand, PD is characterized by neuronal inclusions within nigral DA neurons. These inclusions contain alpha-synuclein, ubiquitin, and various...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
